» Articles » PMID: 12447390

DNA Damage-induced G2-M Checkpoint Activation by Histone H2AX and 53BP1

Abstract

Activation of the ataxia telangiectasia mutated (ATM) kinase triggers diverse cellular responses to ionizing radiation (IR), including the initiation of cell cycle checkpoints. Histone H2AX, p53 binding-protein 1 (53BP1) and Chk2 are targets of ATM-mediated phosphorylation, but little is known about their roles in signalling the presence of DNA damage. Here, we show that mice lacking either H2AX or 53BP1, but not Chk2, manifest a G2-M checkpoint defect close to that observed in ATM(-/-) cells after exposure to low, but not high, doses of IR. Moreover, H2AX regulates the ability of 53BP1 to efficiently accumulate into IR-induced foci. We propose that at threshold levels of DNA damage, H2AX-mediated concentration of 53BP1 at double-strand breaks is essential for the amplification of signals that might otherwise be insufficient to prevent entry of damaged cells into mitosis.

Citing Articles

CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos.

Sala R, Esquer H, Kellett T, Kearns J, Awolade P, Zhou Q Int J Mol Sci. 2024; 25(16).

PMID: 39201277 PMC: 11354643. DOI: 10.3390/ijms25168590.


Transcriptomic response of prostate cancer cells to carbon ion and photon irradiation with focus on androgen receptor and TP53 signaling.

Hanze J, Mengen L, Mernberger M, Tiwari D, Plagge T, Nist A Radiat Oncol. 2024; 19(1):85.

PMID: 38956684 PMC: 11218163. DOI: 10.1186/s13014-024-02480-z.


Involvement of H2A variants in DNA damage response of zygotes.

Wang Y, Tsukioka D, Oda S, Suzuki M, Suzuki Y, Mitani H Cell Death Discov. 2024; 10(1):231.

PMID: 38744857 PMC: 11094039. DOI: 10.1038/s41420-024-01999-0.


Identification of different classes of genome instability suppressor genes through analysis of DNA damage response markers.

Li B, Kolodner R, Putnam C G3 (Bethesda). 2024; 14(6).

PMID: 38526099 PMC: 11152081. DOI: 10.1093/g3journal/jkae064.


Genome scale CRISPR screens identify actin capping proteins as key modulators of therapeutic responses to radiation and immunotherapy.

Verma N, Renauer P, Dong C, Xin S, Lin Q, Zhang F bioRxiv. 2024; .

PMID: 38293095 PMC: 10827061. DOI: 10.1101/2024.01.14.575614.